We have previously reported the characterization of an estrogen-regulated rat uterine-ovarian-specific complementary DNA (UO-44). To understand the involvement of this protein in the initiation and progression of human ovarian and uterine cancers, we now report the cloning and characterization of the human ortholog (HuUO-44). HuUO-44 is mapped to chromosome 10q26.13 and contains nine exons. Multiple tissue Northern blot detected two HuUO-44 transcripts of approximately 2 and 3 kb in the pancreas. RT-PCR demonstrated that HuUO-44 undergoes a complex series of alternative splicing events between exons 2 and 6 that yielded four novel splice variants, HuUO-44A, HuUO-44B, HuUO-44C and HuUO-44D. Putative functional motifs identified in HuUO-44 are two CUB domains and a zona-pellucida domain. Transfection studies demonstrated the membrane-associated nature of HuUO-44. By immunohistochemistry, HuUO-44 was located to the normal ovarian and ovarian tumor epithelial cells; in NIH-OVCAR3 ovarian cancer cells, HuUO-44 was detected only at the leading edge of the dividing cells. Most importantly, a marked loss in cell attachment and proliferation was observed in NIH-OVCAR3 cells cultured in the presence of a polyclonal HuUO-44 antiserum. These findings suggest the potential role of HuUO-44 in cell motility, cell-cell interactions and/or interactions with the extracellular matrices.
Introduction
Estrogens promote growth, differentiation and remodeling of the female reproductive tissues, such as the ovaries and uterus through the modulation of genes that regulate cell growth and differentiation (Yoshinaga et al., 1969; Katzenellenbogen and Gorski, 1975; White et al., 1995; Katzenellenbogen and Korach, 1997) . Tamoxifen is a type 1 (nonsteroidal) antiestrogen that exhibits mixed estrogenic and antiestrogenic activity. In the breast, it acts as an estrogen antagonist and is currently being used in adjuvant therapy for breast cancer prevention and treatment; however, long-term administration may lead to an increased risk of developing ovarian cysts in postmenopausal women (Kazandi et al., 2002) . It has previously been reported that tamoxifen significantly increases uterine weight, whereas ICI 182780 a pure antiestrogen suppresses it (Huynh and Pollak, 1993) .
We previously reported a tamoxifen-induced complementary DNA (cDNA) RatUO-44 (GenBank Accession number AF022147) isolated from rat uterus cDNA library (Huynh et al., 2001) . RatUO-44 is strictly regulated by estrogens, tamoxifen and growth hormone (GH), whereas pure antiestrogen ICI 182780 is inhibitory. Upregulation of RatUO-44 expression in a dosedependent manner has been observed in uterus of ovariectomized and hypophysectomized rats treated with tamoxifen and GH, respectively. Putative functional motifs contained within RatUO-44 are identified as CUB domains and a zona-pellucida (ZP) domain. An identical cDNA sequence of a rat estrogen-regulated gene, ERG1 (GenBank Accession number AF167170) also reported similar findings with the indication of a signal peptide at the amino-terminal (N-terminal) and a transmembrane domain at the carboxyl-terminal (Cterminal) (Chen et al., 1999) . A mouse homolog of RatUO-44 (GenBank Accession number U69699) annotated as an integral membrane-associated protein-1 (Itmap1) has also been isolated from a pregnant mouse uterus cDNA library, their study proposed that the protein plays an important role in uterine events during late pregnancy (Kasik, 1998) . In a more recent report, Itmap1 has also been shown to play an essential role in trypsinogen activation, which contributes to the increased severity of pancreatitis (Imamura et al., 2002) .
Majority of the CUB domain-containing proteins (CDCPs) are developmentally regulated. CDCPs play a part in the mammalian complement system and also aid in protease activation of trypsinogen and cleavage of collagen and fibronectin (Bork and Beckmann, 1993) . Both human and mouse matriptase/MT-SP1, a matrixdegrading transmembrane serine proteinase, contains an arginine-glycine-aspartate (RGD) integrin-binding motif in the first CUB domain. It has been reported that the removal of their cytoplasmic and transmembrane regions causes the protein to remain membrane bound on the surface of COS cells. This suggests the involvement of the CUB motif in integrin-mediated cell surface binding (Takeuchi et al., 2000) . In another report, a novel CDCP-1 has been found highly overexpressed in human colon and lung cancers (Scherl-Mostageer et al., 2001) . Their findings suggest that the upregulation of CDCP1 functions to modulate the cell substrate adhesion or interaction with the extracellular matrices.
ZP domains function as conserved modules for polymerization of extracellular proteins and are also responsible for sperm-adhesion of the ZP (Jovine et al., 2002) . These domains are also present in multidomain transmembrane proteins such as glycoprotein GP2, uromodulin and TGF-b receptor type III (betaglycan) (Bork and Sander, 1992) . Binding studies have shown that the binding of TGF-b to ZP domains surface receptors enhances TGF-b bioactivity (Fukushima et al., 1993) . In this study, we report the cloning, characterization and isolation of four novel splice variants of the human ortholog of the estrogen-regulated protein that is associated to interactions with the extracellular proteins and matrices.
Results

Cloning of human UO-44 (HuUO-44) cDNA
The cDNA sequence of HuU-O44 was obtained through a combination of screening a human uterine cDNA library and 5 0 rapid amplification of cDNA end (RACE). Screening of the cDNA library gave rise to the isolation of four positive clones, of which one harbored the longest insert of about 2.1 kb that was further studied and sequenced (GenBank Accession number AF305835). The rat and human UO-44 were 79 and 73% identical at the nucleotide and peptide levels, respectively. Conserved domain search with the peptide sequence of this library screened HuUO-44 clone identified a region at amino acids 315-558 as a ZP domain; this domain was similar to that found in TGF betaglycan, uromodulin and members of the ZP protein family (Einspanier et al., 1991; Bork and Sander, 1992; Jovine et al., 2002) . 5 0 RACE amplification was performed using 5 0 directed primers located at 150 bp position of the HuUO-44 cDNA cloned from the human uterine cDNA library. We obtained three 5 0 RACE products of 0.2, 0.4 and 1.4 kb in size ( Figure 1 ). Sequences of the three 5 0 RACE products aligned completely at the 3 0 -end and only varied in length at the 5 0 -end. The sequence alignment of the overlapping clones from the 5 0 RACE and cDNA library screened HuUO-44 clone predicted three transcripts of 2.2, 2.4 and 3.3 kb in size.
Genomic structure of HuUO-44
The putative gene structure of HuUO-44 was determined through BLAST search of the human genome data from the NCBI database (www.ncbi. nlm.nih.gov) with the sequences of the three 5 0 RACE contigs. All exon-intron junctions conformed to the splice consensus (5 0 GT/AG3 0 ) rule (Table 1) . Mapped to chromosome 10q26.13, the HuUO-44 gene spans 14 kb and contains nine exons ranging from 151 to 1188 bp and introns ranging from 338 to 4433 bp ( Figure 2 ).
Splice variants of HuUO-44
Tissue expression studies using the Multiple Tissue Northern (MTN) blot detected two transcripts of Figure 1 ). Expression studies of HuUO-44 in normal and tumor ovarian tissues was studied using the cancer profiling array (CPA) ( Figure 4 ) demonstrated higher HuUO-44 expression in 12 of 14 (86%) ovarian tumors compared to corresponding normal tissues. HuUO-44 expression was also higher in the two metastatic ovarian tumors. Expression of the HuUO-44 spliced variants was further investigated using RT-PCR in one paired normal ovarian and ovarian tumor tissues, four cervical cancer cell lines and two ovarian cancer cell lines. The primers used resided in exons 1 and 9; four novel HuUO-44 splice variants were isolated, cloned and sequenced. Alternative splicing was observed between exons 2 and 6 ( Figure 2 ). To obtain a better separation of the bands, RT-PCR was repeated using primers flanking only the spliced exons; the primers used in this nested amplification resided in exons 1 and 7 ( Figure 5 ). The 150 bp band represented the smallest HuUO-44 splice variant, HuUO-44A, this was 1.4 kb in size and contains an ATG in exon 7. HuUO-44A is produced by splicing exons 2-6 (GenBank Accession number AY260050) ( Figure 2 ). Conceptual translation of this mRNA isoform from this ATG yields a protein of 241 amino acids with a predicted molecular mass of approximately 28 kDa. Isoform HuUO-44B is 2 kb in size and is represented by the 750 bp bands, this transcript is obtained through the splicing of exons 2 and, an internally spliced exon 4 and 5 (GenBank Accession number AY260049) ( Figure 2 ). The 900 bp bands represented HuUO-44C that is 2.2 kb in size, this variant is produced by splicing exons 2 and 4 internally (GenBank Accession number AY260048) ( Figure 2 ). The cDNA library screened HuUO-44 clone (GenBank Accession number AF305835) contained exons 4, 5, 6, 7, 8 and 9. This cDNA library screened transcript, HuUO-44B and HuUO-44C contained an ATG at exon 6 encoding for a protein of 326 amino acids with a predicted molecular mass of approximately 36 kDa. HuUO-44D the largest splice variant is 2.3 kb in size and is represented by a 1000 bp band, this transcript is Figure 6 ). The amino acids for polyadenylation signal shown in bold are 80 bp from the stop codon. Signal peptide search predicted a putative signal peptide (at amino acids 1-21) at the N-terminal and a 19 amino acids transmembrane region at the C-terminal. The Nterminal containing the signal peptide, two CUB domains and one ZP domain were predicted to be present in the extracellular region and the remaining 18 amino acids at the C-terminal downstream of the transmembrane region were presumably the cytoplasmic part of HuUO-44. HuUO-44D encoded for two CUB domains and a ZP domain while HuUO-44-A, -B, -C and the cDNA library screened HuUO-44 clone all encoded for only the ZP domain.
Cellular localization of HuUO-44
To further demonstrate the cellular localization of HuUO-44 protein, the ovarian cancer cells, ATCC-NIH-OVCAR3, were transfected with a mammalian expression vector containing the ORF of HuUO-44D fused to the ORF of green fluorescent protein (GFP). HuU-O44 expression was restricted to the cytosol 24 h after transfection and localized to the cell membrane 48 h after transfection, but excluded from the nucleus (Figure 7) . This confirmed the membrane-associated nature of HuUO-44 in the cells. For the pcDNA-GFP control-transfected cells, fluorescence was observed in both the nucleus and cytosol.
Immunohistochemical staining of HuUO-44 in ovarian epithelial tissues and ovarian cancer cell line (NIH-OVCAR3)
A histidine-tagged recombinant protein designed at the ZP domain of HuUO-44 was generated in (BL21-SI) bacteria and purified using a nickel coupled agarose column. Polyclonal antibodies against the purified recombinant protein were raised in rabbits. The specificity of the antibody was determined though excess antigen binding. Immunohistochemistry was performed on eight-chamber slides containing NIH-OVCAR3, ovarian cancer cells and paraffin-embedded sections from human ovarian samples. Strong HuUO-44 immunostaining (in brown) was observed at the cell membrane of the cells and under higher magnification, HuUO-44 was also observed to exclusively localize at the leading edge of the cells (Figure 8a and b ). For the normal ovarian and ovarian tumor sections, HuUO-44 immunostaining was only restricted to the epithelial cells surrounding the stroma cells (Figure 8c and d) .
To determine the expression of HuUO-44 in the normal ovarian epithelium and ovarian tumor tissues, a semiquantitative one-step RT-PCR was performed using primers specific for all the HuUO-44 variants, residing in exons 7 and 9 ( Figure 8e ). The levels of HuUO-44 expression were very similar in the normal ovarian epithelium, ovarian tumors and ovarian epithelial cancer cell line (NIH-OVCAR3). Lower HuUO-44 expression in the normal epithelium sample 2 was probably due to the presence of other contaminating cell types that were not completely removed when the ovarian epithelial layer was peeled.
HuUO-44 antiserum inhibits ovarian cancer cell (NIH-OVCAR3) attachment and cell proliferation
Cell attachment of NIH-OVCAR3 cells were greatly inhibited when cultured in the presence of 10% rabbit HuUO-44 antiserum compared to the 10% preabsorbed antiserum (Figure 9a ). Very few attached cells were observed even at 24 h after seeding the cells in media containing HuUO-44 antiserum. In contrast, attachments of cells were observed as early as 6 h after seeding of the cells in media containing the preabsorbed rabbit HuUO-44 antiserum, cell proliferation was observed at 18 and 24 h postseeding. A marked increased in cell numbers was also observed after 1, 3, 5 and 7 days of culture in media containing preabsorbed antiserum compared to the control antiserum plates (Figure 9b ).
Discussion
We have previously isolated a uterine and ovarian specific, tamoxifen and estrogen-induced rat UO-44 cDNA through differential display and cDNA library screening (Huynh et al., 2001) . Our previous findings demonstrated that estrogen induces the expression of UO-44 while pure antiestrogen ICI 182780 is inhibitory. To further our understanding of UO-44 in the initiation and progression of human ovarian and uterine cancers, we isolated the HuUO-44 through library screening and 5 0 RACE. The rat and human UO-44 shared relatively high sequence similarities both at the nucleotide and peptide levels. The gene was mapped to chromosome 10 q, a region of frequently lost in many malignant tumor types (Gray et al., 1995; Peiffer et al., 1995; Rasheed et al., 1995; Kim et al., 1998; Somerville et al., 1998) .
We have previously shown that the RatUO-44 was highly expressed in the ovaries and uterus; however, the HuUO-44 expression was found highly expressed in the pancreas (Figure 3 ). This differences in the UO-44 expression profile between the rat and human is attributed by the cell type specific nature of UO-44, we Figure 6 Human UO-44 nucleotide sequence (2339 bp) and deduced amino-acid sequence (607 amino acids). The sequence of HuUO-44D isoform is listed above, nucleotides are numbered on the left, and the amino acids are numbered on the right. The translational start site is at the 5 0 end and the polyadenylation signal at the 3 0 untranslated region is in bold. The two CUB domains (CUB-1 and CUB-2) is indicated by and the ZP domain by . The signal peptide (SP) is indicated by ' at the amino terminal and a putative transmembrane region (TM) is indicated by at the carboxyl terminal Membrane-associated protein, CTC Leong et al previously demonstrated using in situ hybridization that UO-44 was restricted to the luminal and glandular epithelial cells in the rat (Huynh et al., 2001) . In comparison, the rat multiple tissue expression profile is a better representation of the actual UO-44 expression as the rat Northern blot was generated using total RNA extracted from whole organs, compared to total RNA extracted from tissue sections used in the human MTN blot. 5 0 RACE amplification established three contigs of 2.2, 2.4 and 3.3 kb in size coincided with the approximately 2 and 3 kb transcripts observed on the MTN (Figure 3) . The sequences of the 5 0 RACE products for the 2.2 and 2.4 kb contigs were mapped to exon 4. This suggested the presence of two possible transcription start sites in exon 4. For the 3.3 kb contig, the transcriptional start site was predicted to be in exon 1. Expression studies of HuUO-44 in a paired normal ovarian tissue and ovarian tumor, ovarian and cervical cancer cell lines using RT-PCR demonstrated that the gene undergoes a complex series of alternative splicing events, which yield four different splice variants that differ in their 5 0 region ( Figure 5 ). These four splice variants; HuUO-44A, -B, -C and -D encoded different functional motifs. The largest splice variant, HuUO-44D, contained two CUB domains and a ZP domain. A bioinformatics assessment under the secreted protein discovery inititive (SPDI) had previously identified more than 1000 secreted and transmembrane human proteins and HuUO-44D was one of these proteins (Clark et al., 2003) . The sequence of HuUO-44D transcript was also annotated as human ERG1 (GenBank Accession number NM022034); however, the publication cited in this annotation contains only data from the rat ERG1 (GenBank Accession number AF167170) (Chen et al., 1999) , no mention of the human homolog was made in their report. HuUO-44B, -C and -D contained only an internally spliced exon 4A of 151 bp (Figure 2 ), while all three 5 0 RACE contigs contained longer exon 4 that varies in sizes (Figure 1) . These larger 5 0 RACE contigs, however, shared the same ORF as HuUO-44B and -C; this suggests that the frame-shift in the ORF caused by the presence of a longer exon 4 may function to regulate the expression of the different functional motifs. The functional roles of these mRNA isoforms are not known at the present time, but one may speculate that the transcriptional regulation and alternate splicing events may function to regulate the gene expression as the choice of transcriptional start sites or the loss of one or more exons might result in a protein that lacks certain functionally important domains. However, this hypothesis requires confirmation by gene expression analysis through silencing or overexpression of each splice variant in cell lines. Studies are underway to examine the molecular events that potentially lead to the activation of this gene.
The genomic structure of HuUO-44 shared high similarity to that of the tumor suppressor DMBT1 located at 10q25.3-26.1 (Mollenhauer et al., 1997; Wu et al., 1999; Lualdi et al., 2000; Mollenhauer et al., 2000) a locus just upstream of HuUO-44. The protein DMBT1 also contained two CUB domains and one ZP domain Figure 6 ). These functional motifs are found in diverse proteins and are evolutionarily highly conserved (Bork and Sander, 1992; Bork and Beckmann, 1993) , suggesting that these domains may play a role in fundamental cellular processes. The close proximity and structural similarities between DMBT1 and HuUO-44, suggest that HuUO-44 could be a product of gene duplication or vice versa. CUB domains are found in developmentally regulated proteins that participate in embryogenesis and organogenesis (Bork and Beckmann, 1993) . The vertebrate bone morphogenetic protein (BMP-1) is one of the CDCPs that is involved in cell adhesion or interaction with the extracellular matrices (Bork and Beckmann, 1993) . Previous studies on a CDCP1, which was upregulated in colorectal cancer, proposed that CUB Figure 9 Effects of HuUO-44 antiserum on cell attachment and proliferation of ovarian cancer cells (NIH-OVCAR3). (a) Each 35 mm plates were seeded with 2 Â 10 5 NIH-OVCAR3 cells in media containing 10% rabbit HuUO-44 antiserum or preabsorbed antiserum. Cell attachment was observed as early as 6 h postseeding in the media containing the preabsorbed HuUO-44 antiserum with cell proliferation observed at 18 and 24 h postseeding. Very few attached cells were observed in the plate containing the HuUO-44 antiserum even at 24 h after seeding cells. (b) Proliferation assay of NIH-OVCAR3 cells seeded in 12-well plates containing the above HuUO-44 antiserum and preabsorbed antiserum media. Exponential increase in cell numbers was observed from Days 1 to 7, in wells containing media supplemented with the preabsorbed antiserum (--), however, cell proliferation was inhibited in the wells containing HuUO-44 antiserum media (-J-). This assay was performed in triplicates and the mean values were used for comparison domains are involved in modulating the cell substrate adhesion or the interaction with the extracellular matrices (Scherl-Mostageer et al., 2001) . In vitro, one of the CUB-containing proteins, bovine acidic seminal fluid protein, was found to function as a mitogen, growth factor and stimulates progesterone secretion in cultured ovarian cells (Einspanier et al., 1991) . Analogous to these findings, we have shown that the antiserum of HuUO-44 a CDCP inhibits cell attachment, thus demonstrating the involvement of HuUO-44 in cell adhesion (Figure 9 ). In ovarian cancer, HuUO-44 may therefore function to promote cell growth and facilitate locoregional invasion.
ZP domain proteins are proteins involved in spermegg recognition found in sperm receptor ZP2 and ZP3 (Bork and Sander, 1992) . This domain is also found in TGF-b receptor type III, uromodulin and the major zymogen granule membrane protein (GP-2) that are related to proteins involved in binding (Einspanier et al., 1991; Bork and Sander, 1992; Jovine et al., 2002) . Each of these ZP domain proteins occurs next to a putative transmembrane region suggesting a conserved biological function of the domain. Consistent to this observation, HuUO-44 contains a ZP domain next to the transmembrane region at the C-terminal. Other common biological properties of ZP domain-containing proteins are: (i) they have all been detected in soluble form, (ii) contain a long hydrophobic sequence segment at or near the C-terminal, and (iii) are heavily glycosylated (Bork and Sander, 1992) . Proteins containing both the CUB and the ZP motifs have a common feature in that they are secreted or located on the cell surface (Bork and Sander, 1992; Bork and Beckmann, 1993) .
The presence of a signal peptide at the amino terminal ( Figure 6 ), one could speculate that HuUO-44 may be located on the cell surface and the signal peptide could signal the secretion of the protein. This membraneassociated nature of the protein was demonstrated through the expression of HuUO-44D tagged with a fusion GFP protein (Figure 7 ) that localized the protein to the cytosol and its subsequent migration to the cell membrane after 48 h. We have also shown by immunohistochemical staining of ovarian sections that HuUO-44 was restricted only to the normal ovarian and ovarian tumor epithelial cells but not in the stroma cells ( Figure  8c and d) . This cell type specific expression of HuUO-44 was confirmed using a semiquantitative RT-PCR of the normal ovarian epithelial layers, ovarian tumors and an ovarian epithelial cancer cell line, which also revealed that the levels of the HuUO-44 transcript in the normal ovarian epithelial layers were similar to that in the ovarian tumor and cell line (Figure 8e ). The ovarian surface epithelium represents a very small fraction of the cell mass in the ovary, however, it gives rise to more than 80% of human ovarian carcinomas (Auersperg et al., 1984; Tsao et al., 1995; Gregoire et al., 2001; Nitta et al., 2001) . The higher transcript expression of HuUO-44 in the tumors observed on the CPA (Figure 4 ) may therefore be due to a greater population of epithelial cells compared to the normal samples, which contained predominantly stroma cells. The epithelial specific expression of HuUO-44, thus suggests that HuUO-44 might be involved in the development of ovarian cancers.
In addition, immunohistochemical staining of HuUO-44 have also revealed that the protein was only restricted to the leading edge of an ovarian cancer cell line (Figure  8a and b) . Furthermore, HuUO-44 antiserum have shown to inhibit ovarian cancer cells attachment and proliferation. The higher transcript levels of HuUO-44 in the metastatic tumor samples shown on the CPA (Figure 4) , thus suggest that the HuUO-44 may promote tumor cell extravasation. The involvement of HuUO-44 in ovarian cancer cell attachment, metastasis and its induction by estrogens (Huynh et al., 2001) , further highlights a potential role of HuUO-44 as a marker for early detection of the cancer or for hormone responsiveness in estrogen or antiestrogen treatment.
Genes that are involved in embryonic development often fulfill analogous roles in cancer (Bhatia-Gaur et al., 1999) . We have previously shown that UO-44 is an estrogen-induced protein; in our present study we have demonstrated the membrane-associated nature and presence of different isoforms of its human ortholog. The presence of a signal peptide, two CUB domains and ZP domain present in the extracellular region, suggest that HuUO-44 may play a role in communication, interaction and signaling with extracellular components and ligands. Importantly, inhibition of NIH-OVCAR3 cell attachment and proliferation by HuUO-44 antiserum suggest that in estrogen-stimulated ovarian cancer cells, the presence of HuUO-44 modulates the interaction with the extracellular matrices, thus constituting to its invasiveness. During cell division, HuUO-44 was localized to the leading edge of the cells; this led to the speculation that protein might play a role in cell motility. Our findings stimulate further investigation into the physiological function of HuUO-44, its regulation and its involvement in tumorigenesis, which may aid in monitoring human ovarian cancers, and/ or as a general marker for estrogen responsiveness.
Materials and methods
Probe labeling
All probes used in library screening, Southern and Northern blot analyses were radioactively labeled with [a-32 P]deoxy-CTP (Perkin-Elmer, Boston, MA, USA) using the Rediprime II DNA Labeling System (Amersham, Pharmacia Biotech, Arlington Heights, IL, USA) as described by the manufacturer. Unincorporated [a-32 P]deoxy-CTP was removed using a nucleotide purification kit (Qiagen, GmbH, Hilden, Germany).
cDNA screening of HuUO-44
To clone its human homolog, a 0.45 kb 3 0 fragment of the 1.9 kb RatUO-44 cDNA (GenBank Accession number AF022147) was used as a hybridization probe to screen about 1 million plaques generated from the Human Adult Uterine Premade cDNA Library (Invitrogen, Carlsbad, CA, USA). Secondary screening was performed and Southern blot analysis was used to confirm clone identity. Positive clones were fully sequenced using T7 (5 0 -TAATACGACTCACTA-TAGGG-3 0 ), SP6 (5 0 -CTATTTAGGTGA CACTATAG-3 0 ), Nested-HuUO-44/F (5 0 -ATGCCAATTCTTACCGGGG-3 0 ) and Nested-HuUO-44/R (5 0 -GAGTTAAAAGCCTCTAGG-TAG-3 0 ) sequencing primers. The authenticity of the clones was verified using automated sequencing (ABI 377) via dideoxy chain termination using the BigDye version 3.0 (Applied Biosystems, CA, USA). Proligo Primers & Probes (Singapore) supplied all primers.
MTN and CPA
The MTN and CPA (Clonetech, CA, USA) blots were hybridized with a 3 0 fragment of HuUO-44 that was 625 bp in size. This probe was radiolabeled and hybridized following the manufacturer's instructions. Glyceraldehydes-3-phosphate dehydrogenase (GAPDH: American Type Culture Collection, Manassas, VA, USA) cDNA probe was used for normalization of the MTN blot, while the CPA was normalized with a ubiquitin probe provided by the manufacturer.
RACE analysis
To establish the full-length cDNA of HuUO-44, 5 0 RACE was performed using the SMARTt RACE cDNA amplification kit (Clonetech, CA, USA) according to the manufacturer's direction with the following modification: The secondary PCR amplifications of the primary RACE products were performed using Advantage s Genomic polymerase (Clonetech, CA, USA), instead of the polymerase recommended, that is, Advantage s 2 Polymerase (Clonetech, CA, USA). Genespecific primer, 5 0 RACE-HuUO-44/R 3 0 (5 0 -AGCTCCAG-CAGAGGTGAGTCCTCTTCCC-3 0 ) was designed based on the 5 0 end sequence of the cDNA library isolated HuUO-44 cDNA. The RACE products were subsequently cloned into pCR s -Blunt-II-TOPO vector (Invitrogen, Carlsbad, CA, USA) and sequenced using T7, SP6, RACE-Nested-HuUO-44/F (5 0 -CTCCAATCACCTGACAGTCT-3 0 ) and RACE-Nested-HuUO-44/R (5 0 -CCACAAAG CCATGATCCTGC-3 0 ) primers. Sequence analysis was carried out using Laser gene sequence analysis software (Dnastar Inc.).
Cloning of different splice variants of HuUO-44 via RT-PCR
Cloning of HuUO-44 cDNA variants was achieved using PCR primers, forward primer FL-HuUO-44/F (5 0 -CACCATGC-CATTGACCCTCTTAATT-3 0 ) designed at the 5 0 end and the reverse primer HuUO-44-E7/R (5 0 -CACAATAATCTG-GAGTTGTTTC-3 0 ) at the 3 0 end. To generate the cDNA template for PCR cloning, total RNA was extracted using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) and 1 mg of total RNA was reversed transcribed using one-step RT-PCR Kit (Qiagen, GmbH, Hilden, Germany) following the manufacturer's instructions. The one-step RT-PCR was performed with following cycles: reverse transcription at 451C for 30 min; activating Taq Polymerase at 951C for 15 min; followed by 30 cycles of 941C for 10 s, 571C for 1 min, 681C for 1 min 30 s, and final extension at 681C for 10 min. The amplified products were separated on a 1% agarose gel and Southern blot was performed to confirm the variants identity. PCR products of the correct size were subsequently cloned into pCR s -Blunt-II-TOPO vector (Invitrogen, Carlsbad, CA, USA) and sequenced using T7 and SP6 primers.
Computational analysis
Sequence identity and prediction of open-reading frames were performed using analysis software from the National Centre for Biotechnology Information (NCBI). The homology studies between rat and human UO-44 were performed at both the nucleotide and the amino-acid levels. The CLUSTAL W v1.82 program (EMBL) was used to perform the multiple sequence alignment. The predicted amino-acid sequences were analysed using Pfam CDS-Conserved Domain Search (NCBI) to detect conserved domains, SignalP (Nielsen and Krogh, 1998) for analysing the presence of signal peptides, SOSUI (Hirokawa et al., 1998) and Tmpred (Hofmann and Stoffel, 1993) program for detection of possible transmembrane regions and NetOGlyc 2.0 program (Blom et al., 1999) to detect possible glycosylation sites.
Genomic structure of HuUO-44
The three 5 0 RACE HuUO-44 contigs were used to BLASTsearch the NCBI human genome database for the HuUO-44 genomic DNA sequence. The intron/exon boundaries were determined through the adherence of the predicted splice signal to the AG/GT rule (Mount, 1982) . The resulting genomic sequences were aligned with the sequences of the four different splice variants using the Laser gene sequence analysis software (Dnastar Inc., USA).
HuUO-44 recombinant protein expression, purification and antibody production
After rare codon analysis, a 600 bp 3 0 region of HuUO-44 cDNA was selected for recombinant protein generation. This region was amplified using HuUO-44/1168F (5 0 -CAC-CATGGCTCTTTTTGAATCCAATTC-3 0 ) and HuUO-44/R (5 0 -GTTAATAGTTCTG CAGCTTCT-3 0 ). The following PCR cycles were used: 951C for 5 min; followed by 25 cycles of 951C for 30 s, 551C for 30 s, 721C for 1 min 30 s, and a final extension of 721C for 5 min. The PCR product was next cloned using the Gateway Expression Systemt (Invitrogen, Carlsbad, CA, USA) into a pDEST-17 vector that contained Histidine tags. The pDEST17-HuUO-44 vector was then transformed into salt inducible BL-21-SI cells. Positive clones were induced in a 500 ml culture with 300 mM NaCl for 5 h and the induced cells were lysed and purified using Nickel-NTA-agarose (Qiagen, GmbH, Hilden, Germany) according to the QIAexpressionist manual provided by the manufacturer. The recombinant protein was dialysed extensively against phosphate-buffered saline (PBS) and concentrated before being used for antibody generation. Polyclonal antibodies were raised in rabbits according to standard protocols. Antisera following the seventh boost were used in these studies. The specificity of the antibodies was verified by Western blot analysis against the recombinant HuUO-44.
Generation of HuUO-44-eGFP-fusion plasmid
Amplification of HuUO-44D transcript containing an openreading frame of 607 amino acids fused to a eGFP protein was achieved using the following primers: Gate-FL-HuUO-44/F (5 0 -CACCATGCCATTGACCCTCTTAA TT-3 0 ), HuUO-44-eGFP/R (5 0 -CTCGCCCTTGCTCACCATATAGTTCTG-CAGCTTCTGG T-3 0 ), eGFP/F (5 0 -ATGGTGAG-CAAGGGCGAG -3 0 ) and eGFP/R (5 0 -TTACTTGTACAG CTCGTCCA-3 0 ). Two separate PCR were performed with the ORF of HuUO-44 amplified using GateHuUO-44/F and HuUO-44-eGFP/R primers, while the ORF of eGFP was amplified using eGFP/F and eGFP/R primers. Next an overlapping PCR was performed with the two previous PCR products as templates using Gate-FL-HuUO-44/F and eGFP/ R primers. All PCR were performed using the following cycles: 951C for 5 min; followed by 25 cycles of 951C for 30 min, 551C for 30 min, 721C for 1 min 30 s, and a final extension of 721C for 5 min. The resulting HuUO-44-eGFP-fusion PCR product was cloned in to a pcDNA3 (Invitrogen, Carlsbad, CA, USA) mammalian expression vector. A eGFP-positive control was constructed with the same strategy using only eGFP/F and eGFP/R primers for PCR.
Transient transfection of ovarian cancer cells
Human ovarian cancer NIH-OVCAR3 cells were maintained as a monolayer culture in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FCS (HyClone, Logan, UT, USA), 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) and grown in a humidified 5% CO 2 atmosphere at 371C. NIH-OVCAR3 cells were seeded at 5 Â 10 5 over cover slips in 100 mm culture dishes 24 h before transfection. Cells were transfected with 10 mg of HuUO-44-eGFP-pcDNA3 or eGFP-pcDNA3, 30 ml of Lipofectamine and 20 ml of Plus reagent (Invitrogen, Carlsbad, CA, USA), following the recommendations of the manufacturer. One cover slip was removed and observed at 24 and 48 h after transfection.
Immunohistochemical analysis
NIH-OVCAR3 ovarian cancer cells were seeded into eightchamber slides 24 h prior to staining. Fixing was performed in 4% formaldehyde for 15 min, followed by two washes with Tris Buffer Saline (20 mM Tris, 200 mM NaCl, pH 7.6) (TBS) for 5 min. For the ovarian tissue samples, prior written informed consent was obtained from patients and the study received Ethics Board approval at the National Cancer Centre of Singapore and Singapore General Hospital, tissue samples obtained were snap frozen in liquid nitrogen. Prior to analysis, the samples from tumors and adjacent were fixed in 10% formalin for 24 h and embedded in paraffin. 5 mM thick sections were cut, dewaxed with xylene, and rehydrated as described (Nielsen and Krogh, 1998) . Antigen retrival was performed by boiling the slides in 10 mM citrate buffer pH 6.0 for 20 min. The following steps were then carried out on both the cell line slides and tissue sections; endogenous peroxidase activity was block by 3% hydrogen peroxide in methanol for 30 min. After two washes of Tris buffer saline (20 mM Tris, 200 mM NaCl, pH 7.6) (TBS), the sections were preincubated with 5% skim milk in TBS containing 0.1% Tween-20 (TBST) for 5 min and incubated overnight at 41C, with purified primary antisera generate against the recombinant HuUO-44. Immunohistochemistry was performed using the strepavidin-biotin peroxidase complex method according to the manufacturer's instructions (Lab Vision, Fremont, CA, USA) using AEC as the chromogen and counterstained with 5% hematoxylin.
Semiquantitative one-step RT-PCR of HuUO-44 in normal ovarian epithelium, ovarian tumor and ovarian epithelial cancer cell line (NIH-OVCAR3)
The normal ovarian epithelium and ovarian tumor samples were obtained from patients and the study received Ethics Board approval at the National Cancer Centre of Singapore and Singapore General Hospital, tissue samples obtained were snap frozen in liquid nitrogen. Total RNA was extracted using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) and 1 mg of total RNA was reversed transcribed using one-step RT-PCR Kit (Qiagen, GmbH, Hilden, Germany) following the manufacturer's instructions. Expression HuUO-44 was analysed using primers specific for all the HuUO-44 variants, residing in exon 7 (HuUO-44/1168F, 5 0 -CACCATGGCTCTTTTT-GAATCCAATTC-3 0 ) and exon 9 (HuUO-44/R, 5 0 -GTTAA-TAG TTCTGCAGCTTCT-3 0 ). The one-step RT-PCR was performed with following cycles: reverse transcription at 451C for 30 min; activating Taq Polymerase at 951C for 15 min; followed by 30 cycles of 941C for 10 s, 571C for 1 min, 681C for 1 min, and final extension at 681C for 10 min. A pair of atubulin primers, TubF (5 0 -AACGTCAAGACGG CCGTGT-3 0 ) and TubR (5 0 -GACAGAGGCAAACTGAGCAC-3 0 ), which amplify a 400 bp fragment of tubulin cDNA for normalization.
Cellular proliferation assays
Preabsorption of the HuUO-44 antiserum was performed by flowing the rabbit HuUO-44 antiserum through a recombinant HuUO-44 protein-coupled CNBr-activated Sepharoset 4B (Amersham, Pharmacia Biotech, Arlington Heights, IL, USA) column. In a 12-well culture plate, 5 Â 10 4 cells were seeded in 2 ml of DMEM (Invitrogen, Carlsbad, CA, USA) containing 1% penicillin/streptomycin (Gibco, Gland Island, NY, USA) and supplemented with either 10% HuUO-44 antiserum or the preabsorbed HuUO-44 antiserum. After 1, 3, 5 and 7 days of incubation (371C, 5% CO 2 ), cells were harvested with trypsin-EDTA solution (Life Technologies, Gaithersburg, MD, USA) and counted using a hemocytometer and trypan blue dye exclusion. Each time point was performed in triplicates and the mean values were used for comparison.
